Summary: Water-suppressed chemical shift magnet ic resonance imaging was used to detect neurochemical al terations in vivo in neurotoxin-induced rat models of Huntington's and Parkinson's disease. The toxins were: N-methyl-4-phenylpyridinium (MPP +), aminooxyacetic acid (A OAA), 3-nitropropionic acid (3 -NP), malonate, and az ide. Local or systemic injection of these com pounds caused secondary excitotoxic lesions by selective inhibition of mitochondrial respirat ion that gave rise to elevated lact ate concentrations in the st riatum. In addi tion , decreased N-acetylaspartate (NAA) concentrations were noted at the lesion site over time. Measurements of lact ate washout kinet ics demonstrat ed that t1/2 fo llowed the order: 3-NP = MPP+ p AOAA = malonate, which parallels the expected lifet imes of the neurotoxins based on their mechanisms of act ion. Further increases in lac tate were also caused by intravenous infusion of glucose. At least part of the excitotoxicity is mediated through
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The biochemical etiology of both Parkinson's and Huntington's disease is unknown. However, sev eral valuable clues have been suggested by neuro toxin models that mimic various neurochemical and indirect glutamate pathways because lactate pr oduction and lesion size were diminished using unilateral decortec tomies (blockade of glutamatergic input) or gluta mate an tagonist s (MK-80 l). Lesion size and lactate were also di minished by energy replet ion with Ubiqu inone and nico tinamide. Lact ate measurements determined by magnetic re sonance agreed with biochemical measurements ma de using freeze clamp techniques. Lesion size as measur ed with MR, although larger by 30%, agreed well with lesion size determined histologically. These experiments pro vide evidence for impairment of intracellular energy me tabolism leading to indirect excitotoxicity for all the com pounds mentioned before and demonstr ate the feasibility of small-volume met abolite imaging for in vi vo neuro chemical analysis. Key Words: Magnetic res onance Spectroscopy-Lactate-E xcitotoxicity-Neurodegen eration-N europrotection.
histological changes seen in the human neurodegen erative illnesses. These models involve the deliber ate (in the case of animals) or accidental (in the case of humans) use of mitochondrial toxins that are po tent blockers of various stages in the electron trans port chain. A working hypothesis of these models is that a defect in oxidative phosphorylation will lead to secondary excitotoxic neuronal degeneration as a result of decreased ATP levels and energy deple tion. This leads to a cascade of events that results in both intracellular and intramitochondrial calcium influx with its attendant toxic sequelae, as well as impaired uptake of glutamate in glial cells leading to further excitotoxicity (Novelli et al., 1988; Blass et al., 1988; Zeevalk and Nicklas, 1991; Beal, 1992; Beal et al., 1993a) . This mechanism may play a role in Parkinson's disease (PD), which has been mod eled using I-methyl-4-phenyl-l,2,3,6-tetrahydro-pyridine (MPTP). MPTP produces parkinsonian symptoms in both nonhuman primates, and in hu mans who had inadvertently injected it (Davis et a!., 1979; Langston et a!., 1983) . MPTP is converted by monoamine oxidase-B to MPP+ (N-methyl-4-phenylpyridinium) that blocks complex I of the mi tochondrial electron transport chain (Furtado and Mazurek, 1991; Tipton and Singer, 1993) . We have also found that aminooxyacetic acid (A OAA), an inhibitor of the malate-aspartate shuttle, can pro duce lesions with a striking sparing of NADPH diaphorase neurons, similar to Huntington's disease (HD) (Beal et a!., 1991) . Another mitochondrial toxin is 3-nitropropionic acid (3-NP), which causes putaminal necrosis accompanied by dystonia and chorea when accidentally ingested in humans (Lu dolph et a!., 1991). It is a suicide inhibitor of succi nate dehydrogenase (complex II) in the electron transport chain, and in vivo can produce degenera tion of the caudate and putamen (Hamilton and Gould, 1987a; Hamilton and Gould, 1987b) . 3-NP and malonate, another complex II inhibitor, may become a valuable model for Huntington's disease. Sodium azide, a cytochrome oxidase (complex IV) inhibitor, also produces basal ganglia degeneration in primates and rodents after systemic administra tion (Mettler, 1972; Miyoshi, 1967) . A schematic for the role of these toxins in the mitochondrial electron transport chain is shown in Fig. I .
One key step in testing the hypothesis that energy impairment can lead to secondary excitotoxic le sions, and identifying the mechanisms of action of these excitotoxins is to find out whether or not they lead to alterations in energy metabolism in vivo. One measure of altered metabolic states is the buildup of cerebral lactate, because its presence is evidence of impairment of oxidative phosphoryla tion. Detection of lactate in vivo by nuclear mag netic resonance (NMR) has been of great interest for many years (Behar et a!., 1983 (Barrere et aI., 1990; Ross, 1991; Behar and Ogino, 1991; Kaup pinen, 1992) . NAA in particular may serve as a use ful marker for lesion progression over time in these animal models due to its nearly exclusive presence in neurons (Birken and Oldendorf, 1989; Urejnak et aI., 1993) .
In this communication we present the application of water-suppressed chemical shift imaging (CSI) experiments to the analysis of several animal mod els of human neurodegenerative diseases. Our goals were (a) to demonstrate that energy impairment can lead to focal lactate buildup and subsequent neuro nal degeneration, (b) to show that indirect gluta mate-mediated excitotoxicity is a common pathway for neuronal death after energy impairment using blockade of both glutamate receptors (via MK-801) and blockade of glutamatergic input to the striatum from cortex via hemidecortectomies, and (c) to show that energy repletion using boosters of mito chondrial energy metabolism may be a rational ther apy for these animal models, and by implication, neurodegenerative illness. CSI offers powerful advantages over traditional biochemical techniques for following lesion pro gression and amelioration over time due to the abil ity to use each animal, in vivo, as its own control. These studies should contribute to understanding the biochemical etiology of diseases such as PD and HD and, in addition, demonstrate the utility of small-volume metabolite imaging for in vivo neuro chemical analysis.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rat s were anesthetiz ed wit h in halati onal methoxyflurane , and immobiliz ed in a st ereo tacti c frame. The skulls were exposed and burr holes were created wit h a dental drill at bregma 2. 6 mm to the left of the sagitt al suture. Injecti ons into the left striata were made at a depth of 4. 5-5. 0 mm from the dura, at a rate of 1 ILl/min wit h a 2-min posti njection dwell time. N-methyl-4-phenylpyridium (MPP+) was injected as 60 nmo1 in 1 ILl of 0. 1 M phosphate buffer, pH 7. 4. AOAA was injected as 3.7 5 ILmol in 1. 5 ILl (adj usted to pH 7.4). Sodium acetate at the same concentrati on and pH served as a control. 3-NP was inject ed as 500 nmol in 1 ILL Mal onate was injected as 3 ILmol in 1. 5 ILL Systemic injec ti ons of 3-NP or azide were delivered vi a an Alzet pump (P alo Alto, CA, U. S. A.) at doses of 15-4 5 mg/ kg/day for variable periods up to 2 weeks. Anesthesia during the MR experiments was maintained by ventilation with a halo thane/N20/02 mixture (1.0% halothane). Animals were maintained at body temperat ure in the magnet by use of a temperature-regulated circulating water blanket kept at 38°C, placed over the animal's body.
]cyclohepten-5, 10-imine maleate), an N-methyl-D as partate (NMDA) ant agonist, was inject ed at the doses st ated in text. Coenzyme QIO (ubiquinone, CoQ) was ad ministered orally by mixing crushed tables into rat chow for 10 days before lesioning at the doses st ated in the text. Nicotinamide was injected intraper itoneally at the st ated doses.
NMR measurements
In vivo imaging experiments were conducted with aGE Omega CS I 4. 7 T machine using a home-built bird-cage coil. The following experiment was performed:
Pr eparation -90slice -TE/2 -2 6 6 2 -TE/ 2 -AQ FIG. 3. Diffusion-weighted, T2-weighted, and N-acetylaspar tate (NAA) images of a rat brain 1 week after stereotaxic in trastriatal injection with malonate. (Field of view for the NAA image was 35 mm, -2 x 2 mm in plane.) Note low NAA in tensity at the lesion site, and high NAA intensity in the lateral septum, which is also well demarcated in the diffusion weighted, but not the T2 image.
J Cereb Blood Flow Metab, Vol. 16, No.3, 1996 where the refocusing pulse is a modified binomial water suppression pulse, and the preparation period consist s of a nonselective Levitt/E rnst-t ype composite inversion pulse (short T inversion recovery) fo llowed a variable de lay, [inversion time (TI)], optimized to give maximal fat and lipid suppression (J enkins et aI., 199 1). TI was changed during the averaging by incrementation between 190 and 220 ms to correct for variable lipid Ti s ar ound the volume of the slice. This method produced an improve ment over a single Tl value by -15%. This technique, combined with the long echo time and the volume coil, as opposed to a surface coil, yielded lipid suppression in the brain region into the noise level while providing uniform met abolite signal-to-noise ratio (SNR) around the entire brain at some expense to the total SNR one might obtain wit h a surface coil (Fernandez et aI., 1992) . Phase encod ing was performed in two dimensions to yield a three dimensional data set (x, y, w) . The entire echo was col lected using a repet ition time (TR) of 2. 2 s and echo time (TE) of 27 2 ms, eight averages, and the field of view was either 35 or 50 mm with 16 x 16 phase-encoding st eps and a 7-mm slice thickness. Th ese parameters correspond to voxels between -40 and 100 fLl and imaging times of 1. 2 h. Signal data were then subjected to three-dimensional Fourier transforms after mUltiplication with a trapezoidal funct ion fo llowed by zero filling. Spatial maps were gen erated by summing toget her the planes defined by the re sonance linewidth in the three-dimensional data set to produce spatial maps. T2, proton-density (p), and diffu sion-weighted imaging were performed using TRITE = 3, 200/ 80, 10 ms for T2 and p respectively, and TRITE = 2,2001 55 ms for diffu sion images wit h isotropic x, y, z gradients of 3 G/cm and 1) = 15 ms and A = 40 ms.
Freeze clamp lactate and lesion size measurements
Fr eeze clamp determinations of lact ate concentrations were made using the method of Schon (Schon, 1965) as reported earlier (Storey et aI., 1992; Brouillet et aI., 1993) . For lesion size measurements brains were quickly re moved and placed in ice cold 0.9% saline solution. Brains were sectioned at 2-mm intervals in a br ain mold. Slices were placed in 2% 2,3, 5-triphenyltetrazolium chloride monohydrat e (TTC) solution, st ained in the dark for 30 min, and then removed and placed in 4% parafor malde hyde at pH 7.3. Lesions were evaluated using a Bioquant IV system.
Lactate concentration estimates
Lactate SNR for the NMR data were measured in mag nitude images. Lactate was measured using a region of interest over the lesion site. To convert this to an estimate of the concentration, the lactate SNR was normalized to the NAA SNR over the control hemisphere or over the entir e brain, where it is assumed that the Tl and T2 val ues of NAA and lactate are the same. This assumpt ion was tested by runni ng Tl and T2 experiments. The Tl values for lact ate and NAA at 4.7 T were = 1. 5 s whereas the T2 values were =260 and 240 ms, respectively. These diff erences were not significant enough to warrant cor recti ons; this is not su rprising given that both resonances are methyl gr ou ps. The available literature on the con centration of N AA in. rat br ains pr esents a range of values between 4 and 8 mM (cf. Bir ken and Oldendorf, 1989 and references therein). After stu dy of the extant lit er ature, we have adopted a value of 7 mM here. We corr ected the SNR values for the statistical properties of noise in mag nitude images wit h low SNRs [i. e. , non-z ero mean, Ray-
Ratio of N-acetylaspartate (NAA) signal-to-noise ratio (SNR) to proton den sity-weighted water SNR in the striatum in control rats and in rats 2.5-3 months after injection with N· methyl-4-phenylpyridin ium (MPP+). On the right is a typical NAA image showing NAA loss in the injected striatum. Note the similar intensity of lesion to brain in the proton density weighted image (TRITE 4,500/ 10 ms) in contrast to a T2-weighted image (see Fig. 3 ). Tables 1-3 . As a further control, met abolit e intensiti es in some cases were also compared wit h water SNR in cor responding voxels from proton-densit y-weighted images. Thi s enables comparison of ab solute metabolit e intensi ti es from ani mal to animal even if the absolute molar con centrations are in error.
T2 lesion siz e was quantitated vi a measurement of sig nal intensity in the contralateral brain area, wit h defini ti on of a lesion as any signal >2.0 SD above the mean signal in the unaffec ted area. The lesion area was then normaliz ed to the total brain slice area.
RESULTS
Energy impairment
Lactate production and NAA depletion. Intrastri atal injections. All of the neurotoxins tested gener ated striatal lactate at varying concentrations after intrastriatal injection. Injections of either saline or sodium acetate as controls did not produce elevated lactate. The general features of all the acute (1 -3 h postinjection) injections were focally increased lac tate, which was reliably localized by the CSI se quence, constant NAA over the brain, and a pro nounced lesion on T2-weighted scans (after 3 h) as shown in Fig. 2 for an intrastriatal injection of AOAA. Interestingly, injection of sodium acetate as a control also produced a lesion on T2-weighted images without corresponding lactate increases, as also seen in Fig. 2 . In these images, which were run with only partial lipid suppression, residual lipid is seen outside the brain; however, no lactate is seen in the acetate-injected animal. Saline injections pro duced no visible T2 lesions or lactate.
One week after injection, no lactate above base line is seen in the lesions caused by either MPP+ , AOAA, malonate, or 3-NP; however, NAA is de pleted and the T2 bright lesions remain, as shown in Fig. 3 for malonate injections (a diffusion-weighted image is shown for comparison). It can be seen that there is a hole in the striatum in the NAA image corresponding to the T2 bright lesion as well as the dark patch in the diffusion-weighted image. Follow up studies indicate further decline in NAA at 2.5-3 months postinjection (relative to water SNR in pro ton density images) as well as the persistence of T2 bright lesions. No lesions were noted on T2 images 1 week after sodium acetate injections (not shown).
To determine the ability of NAA to serve as a measure for neuronal degeneration, we ran CSI im ages of NAA 2.5-3 months after injection with MPP+ as shown in Fig. 4 . Using a ratio of NAA SNR to the SNR from a proton density-weighted image yielded a constant value that allowed abso lute inter-animal comparisons. It is seen that the NAA is depleted by 41 % in the injected striatum compared with uninjected animals. Note also how small the standard deviations are, giving confidence to this technique as a method for absolute NAA quantification. This was tested by comparing the NAA intensity from the ipsilateral to the contralat eral striatum. The ratio in these animals for
[ NAA ]ipsilatera/l NAA ]contralateral indicated 44 ± 4% depletion of NAA in excellent agreement with the absolute measurement. We have recently per-
6 . formed a more detailed comparison of the CSI tech nique with in vitro assays showing its validity (Guimaraes et ai., 1995) . Lactate washout and glucose infusion. Although all the neurotoxins block mitochondrial electron transport, they all have differing properties. For in stance, whereas 3-NP binds irreversibly to complex II, malonate binds reversibly. MPP+ binds near the rotenone binding site of complex I extremely tightly (Tipton and Singer, 1993) . Biodisposition of AOAA is also reversible. Given these facts, one could ex pect lactate production to be transient. We tested this hypothesis by measuring lactate temporally us ing a rapid ID CSI sequence. The first time point comes at �45 min postinjection due to the time re quired to suture, place the animal in the magnet, localize, and shim. Figure 5a shows a curve of lac- To see whether the lactate was actively being produced by way of anaerobic glycolysis (as op posed to a static pool) we performed a lactate stim ulation experiment where we infused glucose 0.2 ml of a 12% solution) into a rat with an intrastriatal injection of AOAA (n = 2). These data are shown in Fig. 5b . It can be seen that there is a transient in crease in the lactate concentration by almost a fac tor of two. A second irijection also gives rise to a transient increase, but lower than the first injection, probably due to washout of AOAA. These data in dicate that there is an active metabolic pool of glu cose-limited oxidatively impaired cells.
AOAA -
Systemic injections. In addition to direct intrastri atal injections of the neurotoxins, systemic injec tions were also performed. Malonate, AOAA, and MPP+ do not cross the blood-brain barrier, but sys temic administration of both 3-NP and azide yields symmetric lesions of the basal ganglia. However, most striking in this regard is that focal lactate pro duction can develop before any lesions are seen in the T2-weighted scans. This is shown in Fig. 6a , where water and lactate images are seen in a rat treated with 3-NP for 2 days. These rats subse quently develop lesions visible to T2-weighted wa ter images as shown, with slight enlargement of the ventricles. Another feature is that the lactate lesion appears larger than the final T2 lesion, indicating that some of the tissue may recover from the energy impairment. These data also indicate that the im pairment of oxidative metabolism caused by 3-NP precedes the damage, which gives rise to the T2 lesion. A similar image is seen for systemic doses of azide after 3 days in Fig. 6b . In this case, lesions were noted in the T2 scan in the dorsal-lateral stri atum, in the same locations as the elevated lactate. In addition, slight signal loss is apparent in the NAA image, which probably indicates some neuronal loss.
Age dependence of blockers of complex II
We previously found that both malonate and 3-NP, which block complex II, show a pronounced vulnerability of the striatum in older rats compared with younger rats (Brouillet et ai., 1993; Henshaw (a) ... -Wt'_g Ih' \\ 1I't:r InIUj:!,l· ... a' du.' knl of lin' sl .. i�.ltml (b) FIG. 6 . a: T2-weighted and lactate images 2 and 5 days after subacute systemic infusion of 3-nitropropionic acid (3-NP). Note focal increase in lactate in the striata and lack of T2-weighted lesions 2 days postinfusion (inplane resolution �3 mm). After 5 days, T2-weighted lesions and enlarged ventricles appear at the level of striatum. Note also the greater size of the lactate lesion compared with the T2 lesion-which is likely a "penumbra" effect in tissue that initially is energy impaired but recovers later. b:
T2-weighted, lactate, and N-acetylaspartate (NAA) images of a rat 7 days after subacute systemic infusion with sodium azide (in-plane resolution �2 mm). Note the symmetric basal ganglia lesions in both the lactate and T2 images, and the subtle loss of NAA in the striata as well.
et aI., 1994). CSI may be an ideal way to follow this age-dependent vulnerability in a longitudinal fash ion. We have now conducted more extensive anal ysis of both the age dependence of lactate produc tion and lesion size for intrastriatal injection of both malonate and 3-NP, including data from 25 animals collected using the 3D CSI technique and T2-weighted imaging. The data indicate a logarithmic dependence on age for both variables as shown in Fig. 7 . We tested whether or not a logarithmic fit was significantly better than a straight linear fit to age using an F test. For the fit of lesion size to age, the probability of the log fit being better was p < 0.05, whereas for the lactate data it was p < 0.1 (due to more scatter in the latter values). The mecha nisms of this potential logarithmic dependence of
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::s c:: Dependence of differential lactate production (Ie sioned minus control striatum) and normalized lesion size (lesion/brain) on age after intrastriatal injection with complex II blockers (3-nitropropionic acid and malonate). Lactate measured using x, y, w chemical shift imaging sequence as described in text. A logarithmic fit to age yields: t1Lactate = -0.40685 + 1.788* log(age); R = 0.834 (p < 10-4 ). Lesion size = -0.024972 + 0.1 091 3* log(age); R = 0.842; (p < 10-4 ).
striatal vulnerability with age for both blockers of complex II remains to be investigated.
Attenuation of excitotoxic lesions
Blockade of glutamatergic input to the striatum.
Evidence of glutamate-mediated excitotoxicity was provided by studies of animals that had unilateral frontal cortical ablations. This removes the cortical glutamatergic input to the striatum and should ame liorate the lesions in the ipsilateral striatum (Storey et aI., 1992; Beal et aI., 1993b) . This is shown in Fig.  8a for a systemic injection of 3-NP. It is apparent that the lactate intensity is considerably lower on the decorticated side. In addition, NAA signal in tensity corresponds very closely to the brain con tour derived from the water image, indicating the good spatial localization of these images. Subse quent histology and biochemistry on the animals showed sparing of the decorticated striatum. Deco rtication also protects against azide lesions as seen in Fig. 8b . This animal also shows diminished lac tate production on the decorticated side. The re sults for differences in the lactate concentrations in the left and right striata in both the decorticated and control animals are presented in Table I . It is obvi ous that the decortication causes a relative decrease in lactate production in the striatum ipsilateral to the decortication. We note that these differences remain statistically significant even if the method is insufficient for absolute quantification. Further proof of glutamate-mediated excitotoxicity is pre sented later herein. Glutamate antagonists. If the lesions generated by impairment of energy metabolism act by way of indirect glutamate excitotoxicity, then they should be blockable by glutamate antagonists. This hy pothesis was tested by use of the well-known NMDA antagonist, MK-801. MK-801 diminished lactate concentration postinjection with either MPP+ or malonate. In addition, lesion size was di minished as measured by either N issl staining or T2-weighted scans. These data are presented in Ta ble 2, which shows lactate measurements were made using both freeze clamp and MR (x, y, w CSI) techniques 3 h after intrastriatal injection with MPP+ without and with pretreatment with two in jections of 5 mg/kg MK-801 (no lactate comparisons are shown for malonate with this protocol due to the time dependence of both the lactate washout and the MK-801 treatment). The agreement between the freeze clamp and MR measurements is so close that it is probably fortuitous; nevertheless, it lends con fidence to the MR technique, which has a lower standard deviation than the biochemical technique. These d"\ta, and others not shown, indicate that glu- tamate-mediated excitotoxicity is a common path way for neuronal death. Energy repletion. Excitotoxic lesions caused by impairment of energy metabolism should be par tially capable of amelioration by way of energy re pletion. Logical candidates for such repletion are compounds that can aid in electron transport through the electron transport chain (ETC). We chose to study the effects of energy repletion using coenzyme Q] O (Ubiquinone, CoQ) and/or nicotin amide. Fig. 9 shows the effect of nicotinamide on both lesion size and lactate concentration after in trastriatal malonate injection. It is apparent that the lactate peak has been reduced to the noise level in this animal and that the T2 lesion is substantially reduced. For comparison, a similar set of images is shown for pretreatment with the combination of both CoQ and nicotinamide where the lesion size has been reduced even further.
These data are summarized in Table 3 . In this table, lesion size measurements using both TTC staining and MR T2 are shown for comparison re ported as percent of control. Lesion size reduction after treatment with CoQ (200 mg/kg) showed ex cellent agreement as assessed by either TTC or MR imaging when measured as percent of control. The absolute values of the TTC lesion sizes ranged from 1 to 7% of brain slice area, whereas for T2 the num bers were 2-9% (total brain areas =600 mm2). How ever, the average TTC lesion was smaller than the average MR lesion by 29 ± 9% due likely to the inclusion of some nonspecific edema in the case of the T2 measurements. For the combination of nic otinamide and CoQ, the lesion size measured by MR was substantially larger than that with the TTC staining (52 versus 28%). 
9.3 ± 2.4
4.3 ± 2.1 (p < 0.02) b
12.1 ± 3.6
7.3 ± 2.6 (p < 0.05) b a p value for difference in means between lesioned striatum and contralateral (control) striatum, paired, two-tailed t test.
b p value for difference in means between rats treated with and without MK-SOl, unpaired, two tailed t test. All errors are standard deviations.
It is apparent that both CoQ and nicotinamide are successful in diminishing both lactate production and lesion size; however, a combination of CoQ plus nicotinamide is more effective than either alone (Table 3) . Although the lactate percent reduc tion appears to be lower in the nicotinamide-treated animal than in the CoQ plus nicotinamide-treated animal, this was largely due to an outlier in the lat ter data set. Removal of this outlier (in which lac tate concentration was 2.0 mM versus an average of 0.55 ± 0. 09 mM for the other three animals) yielded smaller lactate concentrations in the nicotinamide plus CoQ-treated animals compared with nicotin amide alone. These numbers were 1.05 for nicotin amide alone versus 0. 55 mM for the combination (a reduction to 26% of control). The latter number is essentially equivalent to reduction to unlesioned control values of lactate concentration.
DISCUSSION
The present experiments provide important new data concerning potential etiologic mechanisms in neurodegenerative diseases and the application of MR to the study of models of these conditions. We have shown in prior work that AOAA, 3-NP, and malonate can reproduce many of the biochemical findings characteristic of HD (Beal et aI. , 1991 ; Brouillet et aI. , 1993; Beal et aI. , 1993b; Henshaw et aI. , 1994) . MPP+ is also well known to replicate many features characteristic of PD (Langston et aI. , 1983; Furtado and Mazurek, 1991 ; Storey et aI. , 1992; Tipton and Singer, 1993) . The experiments here show that these toxins produce marked local increases in lactate via intrastriatal injection consis tent with impaired oxidative phosphorylation, within a brain region that subsequently shows neu ronal degradation by histological, neurochemical, and MR methods. In addition, systemic administra tion of azide and 3-NP produced focal buildup of lactate and lesions in the striatum, the area first afflicted in HD. The CSI sequence used here was able to not only localize the lactate lesion quite re liably, but also to provide quantitative estimates of concentrations that agree quite well with concentra tions measured using freeze-clamp biochemistry (Table 2) .
These experiments thus provide valuable in vivo evidence for the hypothesis that energy impairment can lead secondarily to excitotoxic neuronal death (Novelli et a!. , 1988; Blass et aI. , 1988; Zeevalk and Nicklas, 1991 ; Beal, 1992; Beal et aI. , 1993a) . Most convincing in this regard is that systemic adminis tration of both 3-NP and azide produce lactate le sions localized to the striatum that precede the de velopment of the lesions seen in the T2-weighted water images (Fig. 6) . Another feature is that the lactate lesions often appear larger than the T2-weighted or histological lesions (Fig. 6a) , indicating that there may be an area of tissue that recovers from the energy impairment, similar to what is seen with the ischemic penumbra in focal ischemia models. The mechanism behind these changes can be ex plained by relief of the voltage-dependent Mg2 + block of the NMDA receptor resulting from depolariza tion of the cell membrane, caused by ATP depletion as a consequence of blockage of electron transport (Zeevalk and Nicklas, 1991 ; Beal et aI. , 1993a) . 
Lactate
Same study for a rat pretreated with both nicotinamide and CoQ (lesion area �26 mm 2 in the control and 5 mm 2 in the treated animal). Lactate was measured using a rapid one-dimensional chemical shift imaging sequence (y, w) as de scribed in text. Spectra are magnitude spectra representing two lines through the striatal area.
Measurement of the lactate concentrations as a function of time yielded information on the mecha nism of energy impairment. Specifically, the time for the lactate concentration to halve (t1/2) as shown in itor of succinate dehydrogenase and MPP+ has an extremely long lifetime in the rotenone binding site of complex I (Tipton and Singer, \993) . In the only other data of this type that we are aware of, in vivo microdialysis of lactate production after lesioning with NMDA showed a t 1/2 of -8 min (Kuhr and Korf, 1988) . This is reasonable, because NMDA should be subject to glutamate reuptake mecha nisms, making its energy impairmem: transitory and rather fast compared with these other toxins. These experiments also demonstrate the ability of glucose to transiently boost production of lactate. This ef fect can also be induced in ischemic conditions, demonstrating substrate-limited anerobic glycoly sis.
In addition to its ability to follow lactate as a marker of metabolism, CSI is well suited to a role for determining neuronal loss using N AA as a marker. The loss of NAA over time was readily measured using MR techniques (Figs. 3 and 4) . We have previously shown that this CSI technique pro vides excellent agreement with in vitro measures of NAA loss in similar rat models (Guimaraes et aI. , 1995) . This makes it feasible to follow the same an imal over time to assay lesion progression in con trast to conventional biochemical techniques. In this context, NAA serves as an anatomic neuronal marker, whereas lactate serves as a functional met abolic marker.
. MR imaging also proves to be a useful tool for assessing the age dependence of complex II inhibi tors. Our data clearly show that both malonate and 3-NP evince a pronounced vulnerability of the stri atum as a function of age. This is revealed in both excess lactate production as a function of age as well as increased lesion size. Interestingly, this same behavior was not seen with MPP + (not shown). This may be related to the age-dependent decline in activity that has been reported for com plex I, but not II, in recent studies of rat respira tory muscle (Torii et aI. , 1992) . This age depen dence has profound implications for study of the age-dependent onset of neurodegenerative disor ders, because it provides a plausible explanation for why increasing age might be a risk factor (Wallace, 1992; Mecocci et aI. , 1993) . Because HD typically shows an onset at early middle age, and increasing age is the major risk factor for both PD and Alzhei mer's disease, these toxins may become standard animal models of neurodegeneration. That the age dependent vulnerability of the striatum is logarith mic rather than linear is at this point not under stood; however, it certainly warrants additional study because it may yield further insight into the actual mechanism of neurodegeneration.
A further role of CSI is in its ability to assess neuroprotection. Our data clearly indicate that both lesion size and lactate production can be diminished using hemidecortectomies and MK-80 1, both of which act to block glutamate-mediated excitotoxic ity ' including, but not necessarily limited to, NMDA glutamate receptors. CSI was capable of producing spatially resolved images of NAA and lactate that readily demonstrated neuroprotection. The excel lent concordance between the MR and biochemical freeze-clamp measurements of lactate (Table 2) lends credence to the in vivo capability of MR lac tate quantitation. Our data also demonstrate the protective effects of MK -80 1 on MPP + toxicity in contrast to a prior report (Sonsalla et aI. , 1992) but in agreement with another (Turski et aI. , 1991) . In addition, we have shown that boosters of mitochon drial energy metabolism (coenzyme Q IO or ubiqui none and nicotinamide) can also lead to diminished lesion size and lower lactate production. The finding that energy repletion can produce neuronal protection against excitotoxic lesions is exciting, because it immediately suggests a possible therapeutic role for these agents in neurodegenera tive illnesses and a role for MR in following this potential therapy. A preliminary account of just such an approach has been reported using CoQ in HD patients (Jenkins et aI. , 1993) . Although these studies do not confirm the mechanism by which these agents work, due to ubiquinone's ability to act as a free radical scavenger as well as an electron transporter, they nonetheless unequivocally indi cate their effectiveness with specific mitochondrial poisons. Thus, it is likely that their beneficent role in the electron transport chain is at least in part responsible for their efficacy.
CSI should become an important adjunct to ex isting neurochemical techniques by producing maps of relevant cerebral metabolites in vivo. Most tech niques now in use rely on postmortem assessment of lesion chemistry. We believe that CSI offers some powerful and complementary advantages over conventional biochemical techniques, not the least of which is that CSI allows for follow-up stud ies to be performed on a single animal, yielding im portant information regarding lesion progression over time, using each animal as its own control. An additional advantage of MR imaging is that one can obtain two measures for the price of one-lactate for functional metabolism, and NAA for neuronal anatomy. Of course there are many other chemicals such as glutamate and GABA one can follow that may also yield novel information on neurodegener ation. MR imaging may prove to be invaluable in screening potential therapeutic strategies in animal models of neurodegeneration. Application of this technology to both animal models of human neuro degenerative illnesses, and to the human illnesses themselves, may yield important new information about the pathogenesis of these diseases.
